BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10611554)

  • 1. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
    Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA; Yernault JC; Demedts MG; Geusens P
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma.
    Ferguson AC; Van Bever HP; Teper AM; Lasytsya O; Goldfrad CH; Whitehead PJ
    Respir Med; 2007 Jan; 101(1):118-29. PubMed ID: 16735113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma].
    Zhong NS; Zheng JP; Cai BQ; Xie CM; Sun TY; Wang DQ; Lin YP; Chen BY; Tao JJ; Kang J; Li Q; Xu YP; Zhou X; Guo XJ; Chen XD; Yin KS; Zhang DP; Zhou JY; Shen HH; Qiu C; Feng YL; Xiao BR
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):233-7. PubMed ID: 15854431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
    Weng JL; Zheng YS; Ma QF
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C; Allegra L; Barkai L; Cremonesi G
    Eur Rev Med Pharmacol Sci; 2001; 5(1):17-24. PubMed ID: 11860218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
    Ställberg B; Pilman E; Skoogh BE; Hermansson BA
    Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
    Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
    Harmanci E; Colak O; Metintas M; Alatas O; Yurdasiper A
    Allergol Immunopathol (Madr); 2001; 29(1):22-7. PubMed ID: 11449531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
    Kannisto S; Korppi M; Remes K; Voutilainen R
    J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H; Yamase H
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.